Relatively rapid evolution rates of SARS-CoV-2 spike gene at the primary stage of massive vaccination

World Health Organization, WHO coronavirus (COVID-19) dashboard. https://covid19.who.int, 2020 (accessed 28 May, 2022). Tian, 2020, An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China, Science, 368, 638, 10.1126/science.abb6105 Li, 2020, Global COVID-19 pandemic demands joint interventions for the suppression of future waves, Proc. Natl. Acad. Sci. U. S. A., 117, 26151, 10.1073/pnas.2012002117 Lai, 2020, Effect of non-pharmaceutical interventions to contain COVID-19 in China, Nature, 585, 410, 10.1038/s41586-020-2293-x Yang, 2020, Uncovering two phases of early intercontinental COVID-19 transmission dynamics, J. Travel Med., 27, 10.1093/jtm/taaa200 Dai, 2020, A universal design of Betacoronavirus vaccines against COVID-19, MERS, and SARS, Cell, 182, 722, 10.1016/j.cell.2020.06.035 Corbett, 2020, SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness, Nature, 586, 567, 10.1038/s41586-020-2622-0 Pritchard, 2021, Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom, Nat. Med., 27, 1370, 10.1038/s41591-021-01410-w Rossman, 2021, COVID-19 dynamics after a national immunization program in Israel, Nat. Med., 27, 1055, 10.1038/s41591-021-01337-2 Zhao, 2021, Neutralisation of ZF2001-elicited antisera to SARS-CoV-2 variants, Lancet Microbe, 2, e283, 10.1016/S2666-5247(21)00217-2 Tillett, 2021, Genomic evidence for reinfection with SARS-CoV-2: a case study, Lancet Infect. Dis., 21, 52, 10.1016/S1473-3099(20)30764-7 Han, 2021, Distinct durability of IgM/IgG antibody responses in COVID-19 patients with differing severity, Sci. China Life Sci., 2, 1 Niesen, 2021, COVID-19 vaccines dampen genomic diversity of SARS-CoV-2: unvaccinated patients exhibit more antigenic mutational variance [Preprint], medRxiv Bergwerk, 2021, COVID-19 Breakthrough infections in vaccinated health care workers, N. Engl. J. Med., 385, 1474, 10.1056/NEJMoa2109072 Katoh, 2013, MAFFT multiple sequence alignment software version 7: improvements in performance and usability, Mol. Biol. Evol., 30, 772, 10.1093/molbev/mst010 M.A. Suchard, P. Lemey, G. Baele, et al., Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10, Virus Evol. 4 (2018), vey016. https://doi.org/10.1093/ve/vey016. A. Rambaut, A.J. Drummond, D. Xie, et al., Posterior summarization in Bayesian phylogenetics using Tracer 1.7, Syst Biol. 67 (2018) 901–904, https://doi.org/10.1093/sysbio/syy032. Dai, 2021, Viral targets for vaccines against COVID-19, Nat. Rev. Immunol., 21, 73, 10.1038/s41577-020-00480-0 Huan, 2019, Research progress and prospect of vaccines for the coronavirus disease COVID-19), Sci. Sin. Vitae., 52, 237 Harvey, 2021, SARS-CoV-2 variants, spike mutations and immune escape, Nat. Rev. Microbiol., 19, 409, 10.1038/s41579-021-00573-0 Garcia-Beltran, 2021, Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity, Cell 184, 184, 2372, 10.1016/j.cell.2021.03.013 Falsey, 2021, SARS-CoV-2 neutralization with BNT162b2 vaccine dose 3, N. Engl. J. Med., 385, 1627, 10.1056/NEJMc2113468 Barda, 2021, Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study, Lancet, 398, 2093, 10.1016/S0140-6736(21)02249-2 Xu, 2021, Humoral and cellular immunity and the safety of COVID-19 vaccines: a summary of data published by 21 May 2021, Int Immunol., 33, 529, 10.1093/intimm/dxab061 Sahin, 2021, BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans, Nature, 595, 572, 10.1038/s41586-021-03653-6 Cobey, 2021, Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination, Nat. Rev. Immunol., 21, 330, 10.1038/s41577-021-00544-9 Saad-Roy, 2021, Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes, Science, 372, 363, 10.1126/science.abg8663